Vascular reactivity in patients with undifferentiated connective tissue diseases

Atherosclerosis

Volumn 203, Issue 1, 2009, Pages 185-191

  Mosca, Marta ^a   Virdis, Agostino ^a   Tani, Chiara ^a   Ghiadoni, Lorenzo ^a   Versari, Daniele ^a   Duranti, Emiliano ^a   d'Ascanio, Anna ^a   Salvetti, Antonio ^a   Taddei, Stefano ^a   Bombardieri, Stefano ^a  

^a UNIVERSITY OF PISA   (Italy)

Author keywords

Atherosclerosis; Endothelial function; Nitric oxide synthase; Undifferentiated connective tissue diseases

Indexed keywords

ACETYLCHOLINE; GLYCERYL TRINITRATE; N(G) METHYLARGININE; NITRIC OXIDE; NITROPRUSSIDE SODIUM;

ADULT; ARTICLE; ATHEROSCLEROSIS; BLOOD VESSEL REACTIVITY; BRACHIAL ARTERY; CLINICAL ARTICLE; CONNECTIVE TISSUE DISEASE; CONTROLLED STUDY; FEMALE; FOREARM BLOOD FLOW; HUMAN; MALE; MICROCIRCULATION; PRIORITY JOURNAL; RISK FACTOR; VASCULAR ENDOTHELIUM; VASODILATATION;

ACETYLCHOLINE; ADULT; BRACHIAL ARTERY; CARDIOVASCULAR DISEASES; CASE-CONTROL STUDIES; CONNECTIVE TISSUE DISEASES; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; MALE; MICROCIRCULATION; MIDDLE AGED; NITRIC OXIDE; NITROGLYCERIN; NITROPRUSSIDE; RISK FACTORS; VASODILATION;

EID: 60649095137     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2008.06.021     Document Type: Article

References (30)

1. Svenungsson E., Jensen-Urstad K., Heimburger M., et al. Risk factors for cardiovascular disease in systemic lupus erythematosus. Circulation 104 (2001) 1887-1893
2. Bruce I.N., Urowitz M.B., Gladman D.D., Ibanez D., and Steiner G. Risk factors for coronary heart disease in women with systemic lupus erythematosus: the Toronto risk factor study. Arthritis Rheum 48 (2003) 3159-3167
3. Roman M.J., Shanker B.A., Davis A., et al. Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus. N Engl J Med 349 (2003) 2399-2406
4. Bruce I.N. 'Not only...but also': factors that contribute to accelerated atherosclerosis and premature coronary heart disease in systemic lupus erythematosus. Rheumatology (Oxford) 44 (2005) 1492-1502
5. Wada Y., Kuroda T., Murasawa A., et al. Autoantibodies against oxidized low-density lipoprotein (LDL) and carotid atherosclerosis in patients with rheumatoid arthritis. Clin Exp Rheumatol 23 (2005) 482-486
6. Taddei S., and Salvetti A. Endothelial dysfunction in essential hypertension: clinical implications. J Hypertens 20 (2002) 1671-1674
7. Brunner H., Cockcroft J.R., Deanfield J., et al. Endothelial function and dysfunction. Part II: association with cardiovascular risk factors and diseases. A statement by the working group on endothelins and endothelial factors of the European society of hypertension. J Hypertens 23 (2005) 233-246
8. Lerman A., and Zeiher A.M. Endothelial function: cardiac events. Circulation 111 (2005) 363-368
9. Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med 340 (1999) 115-126
10. Taddei S., Caraccio N., Virdis A., et al. Impaired endothelium-dependent vasodilatation in subclinical hypothyroidism: beneficial effect of levothyroxine therapy. J Clin Endocrinol Metab 88 (2003) 3731-3737
11. Taddei S., Caraccio N., Virdis A., et al. Low-grade systemic inflammation causes endothelial dysfunction in patients with Hashimoto's thyroiditis. J Clin Endocrinol Metab 91 (2006) 5076-5082
12. Vaudo G., Marchesi S., Gerli R., et al. Endothelial dysfunction in young patients with rheumatoid arthritis and low disease activity. Ann Rheum Dis 63 (2004) 31-35
13. Bergholm R., Leirisalo-Repo M., Vehkavaara S., et al. Impaired responsiveness to NO in newly diagnosed patients with rheumatoid arthritis. Arterioscler Thromb Vasc Biol 22 (2002) 1637-1641
14. Lima D.S., Sato E.I., Lima V.C., Miranda Jr. F., and Hatta F.H. Brachial endothelial function is impaired in patients with systemic lupus erythematosus. J Rheumatol 29 (2002) 292-297
15. El-Magadmi M., Bodill H., Ahmad Y., et al. Systemic lupus erythematosus: an independent risk factor for endothelial dysfunction in women. Circulation 110 (2004) 399-404
16. Wright S.A., O'Prey F.M., Rea D.J., et al. Microcirculatory hemodynamics and endothelial dysfunction in systemic lupus erythematosus. Arterioscler Thromb Vasc Biol 26 (2006) 2281-2287
17. Booth A.D., Wallace S., McEniery C.M., et al. Inflammation and arterial stiffness in systemic vasculitis: a model of vascular inflammation. Arthritis Rheum 50 (2004) 581-588
18. Mosca M., Baldini C., and Bombardieri S. Undifferentiated connective tissue diseases in 2004. Clin Exp Rheumatol 22 (2004) S14-18
19. Mosca M., Tani C., and Bombardieri S. Defining undifferentiated connective tissue diseases: a challenge for rheumatologists. Lupus 17 (2008) 278-280
20. Mancia G., De Backer G., Dominiczak A., et al. Guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European society of hypertension (ESH) and of the European society of cardiology (ESC). J Hypertens 25 (2007) 1105-1187
21. Deanfield J., Donald A., Ferri C., et al. Endothelial function and dysfunction. Part I: methodological issues for assessment in the different vascular beds: a statement by the working group on endothelin and endothelial factors of the European society of hypertension. J Hypertens 23 (2005) 7-17
22. Ghiadoni L., Magagna A., Versari D., et al. Different effect of antihypertensive drugs on conduit artery endothelial function. Hypertension 41 (2003) 1281-1286
23. Taddei S., Virdis A., Ghiadoni L., Magagna A., and Salvetti A. Vitamin C improves endothelium-dependent vasodilation by restoring nitric oxide activity in essential hypertension. Circulation 97 (1998) 2222-2229
24. Virdis A., Ghiadoni L., Cardinal H., et al. Mechanisms responsible for endothelial dysfunction induced by fasting hyperhomocystinemia in normotensive subjects and patients with essential hypertension. J Am Coll Cardiol 38 (2001) 1106-1115
25. Deanfield J.E., Halcox J.P., and Rabelink T.J. Endothelial function and dysfunction: testing and clinical relevance. Circulation 115 (2007) 1285-1295
26. Taddei S., Versari D., Cipriano A., et al. Identification of a cytochrome P450 2C9-derived endothelium-derived hyperpolarizing factor in essential hypertensive patients. J Am Coll Cardiol 48 (2006) 508-515
27. Taddei S., Virdis A., Ghiadoni L., et al. Vasoconstriction to endogenous endothelin-1 is increased in the peripheral circulation of patients with essential hypertension. Circulation 100 (1999) 1680-1683
28. Werner N., Kosiol S., Schiegl T., et al. Circulating endothelial progenitor cells and cardiovascular outcomes. N Engl J Med 353 (2005) 999-1007
29. Grisar J., Aletaha D., Steiner C.W., et al. Depletion of endothelial progenitor cells in the peripheral blood of patients with rheumatoid arthritis. Circulation 111 (2005) 204-211
30. Fadini G.P., Baesso I., Albiero M., et al. Technical notes on endothelial progenitor cells: ways to escape from the knowledge plateau. Atherosclerosis 197 (2008) 496-503